Sign In

Drew Spaventa

Chairman, CEO, Founder at Singular Genomics

Drew Spaventa is an accomplished Venture Partner and executive with a strong background in venture capital and private equity.

He possesses a diverse skill set in DNA Sequencing, Sales, Entrepreneurship, Venture Capital, and Strategic Partnerships.

Drew's educational background includes an MBA in Finance from the University of California, San Diego - Rady School of Management, studies at the University of San Diego School of Law, and a Bachelor of Arts in Political Science and International Relations from the University of California, San Diego.

Throughout his career, Drew has held prominent positions in various organizations, such as Chairman, CEO, and Founder at Singular Genomics, Board Member and Seed Investor at Aspen Neuroscience, and Board Member at the San Diego Venture Group.

He has also been actively involved in ventures like Truvian Sciences, Axon Ventures, Edico Genome, ecoATM Gazelle, CIM Securities, Tyche Global Strategy, and Gecko Logic USA.

Highlights

Feb 9 · linkedin

Earlier this week at #AGBT, we announced the G4X Spatial Sequencer, the first instrument of its kind. The G4X leverages our rapid NGS chemistry to do in-situ spatial sequencing of RNA inside cells, in tissue at unprecedented scale. The use of sequencing to offer innovative solutions in spatial biology has been an area of work at Singular for many years. The potential impact of this technology on the scientific and medical community is what excites us most. I want to thank the incredibly talented and dedicated team at Singular for getting us to this point, and for their continued work to get this technology to market as soon as possible. This next chapter should be exciting.

Drew Spaventa
Add to my network

Location

San Diego, California, United States